On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data
Harvard University · Cancer Research And Biostatistics · +4 more institutions
Abstract
For modern evidence-based medicine, a well thought-out risk scoring system for predicting the occurrence of a clinical event plays an important role in selecting prevention and treatment strategies. Such an index system is often established based on the subject's 'baseline' genetic or clinical markers via a working parametric or semi-parametric model. To evaluate the adequacy of such a system, C-statistics are routinely used in the medical literature to quantify the capacity of the estimated risk score in discriminating among subjects with different event times. The C-statistic provides a global assessment of a fitted survival model for the continuous event time rather than focussing on the prediction of…
Citation impact
- FWCI
- 116.50
- Percentile
- 100%
- References
- 37
Authors
5- HUHajime UnoCorresponding
Harvard University, Cancer Research And Biostatistics, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center
- TCTianxi Cai
Harvard University, Cancer Research And Biostatistics
- MPMichael Pencina
Boston University
- RBRalph B. D’Agostino
Boston University, University of Massachusetts Boston
- LJL. J. Wei
Harvard University, Cancer Research And Biostatistics
Topics & keywords
- Censoring (clinical trials)
- Statistics
- Statistic
- Estimator
- Parametric statistics
- Concordance
- Population
- Survival analysis
- Reduced inequalities